Preparation method of aromatic ether compounds

By using a specific solvent system to optimize the preparation process of nitrohydroxyquinoline prodrug in the presence of catalysts and alkalis, the problem of low reaction conversion in the prior art is solved, the overall yield and product purity are improved, and it is suitable for industrial production.

CN115697970BActive Publication Date: 2024-11-15JIANGSU YAHONG MEDITECH CO LTD +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202180042597.4
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2020-06-22
Filing Date
2021-05-27
Publication Date
2024-11-15
Estimated Expiration
2041-05-27

AI Technical Summary

Technical Problem

In the existing preparation methods of nitrohydroxyquinoline, the conversion rate of the first step reaction is low, resulting in a lower yield of the overall synthetic route. The short biological half-life of the drug requires frequent administration to increase the economic burden and cause normal organisms. Continuous damage.

Method used

In the presence of catalyst and base, compound V reacts with compound 6, adopts specific solvent systems and reaction conditions to improve the reaction conversion, including the use of tetrabutylammonium hydroxide and sodium bicarbonate as catalysts and bases, water, tetrahydrofuran, 2-methyl As solvents, tetrahydrofuran and ethyl acetate control the reaction temperature and molar ratio and optimize the preparation process of compound VII.

Benefits of technology

The conversion rate and overall yield of the first step reaction are significantly improved, the post-treatment and purification operation of Compound VII is simplified, suitable for industrial production, and the purity and yield of the product are improved.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN115697970B_ABST
    Figure CN115697970B_ABST
Patent Text Reader

Abstract

A method for preparing an aromatic ether compound. The method comprises the following steps: c) reacting compound V with compound 6 in a solvent in the presence of a catalyst and a base to obtain compound VII; the solvent is a binary or higher solvent system selected from water, tetrahydrofuran, 2-methyltetrahydrofuran, ethyl acetate and dioxane. The method for preparing an aromatic ether compound of the present invention can greatly improve the conversion rate of the above reaction, thereby improving the yield of this step and the total yield of the entire reaction route; the post-treatment and purification operation of preparing compound VII is greatly simplified, and the reaction solution only needs to be filtered, the filter cake washed and dried to obtain compound VII with high purity, which is suitable for industrial scale-up production.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to a method for preparing aromatic ether compounds. Background Art

[0002] Nitroxoline, as an antibacterial drug that has been marketed, has long been used to treat urinary tract infections. Recent discoveries have shown that nitroxoline is also very effective in inhibiting angiogenesis and inhibiting the growth and invasion of cancer cells, and is currently being developed for anti-tumor use. Human pharmacokinetic studies have shown that nitroxoline can be rapidly absorbed into the blood circulation, but due to the severe first-pass effect of the liver on the drug, its biological half-life is very short (according to a single-arm, open, multi-center clinical phase II experiment conducted in China by Jiangsu Yahong Pharmaceutical Technology Co., Ltd., its half-life is 1.22-1.44 hours), and frequent administration is required. In order to maintain continuous drug exposure, nitroxoline drugs are generally prescribed to be taken three times a day (TID) or four times a day (QID), which not only brings economic losses and is not conducive to patient compliance, but more seriously increases the drug's continued damage to the normal body. At the same time, because nitroxoline has a very low water solubility, it is often necessary to make it into a rapid-release preparation to improve solubility, which invisibly increases production costs.

[0003] Prodrugs are chemically modified compounds of active drugs, which are converted into the original drugs in vivo by enzymes to exert their efficacy. Prodrugs are widely used in drug research and development, and have been successfully studied in many different drugs and have achieved good application results. The prodrug strategy can solve some defects of the parent drug (active agent) due to its own physical and chemical properties, such as: 1) eliminating the bad smell of the drug; 2) increasing the blood drug concentration; 3) increasing the lipid solubility or water solubility of the drug; 4) prolonging the duration of action of the drug; 5) changing the route of drug administration, etc.

[0004] ((5-nitroquinolin-8-yl)oxy)methyl isobutyryl-L-proline ester is a prodrug of nitroquinoline, which can solve the above-mentioned defects of nitroquinoline. At present, only patent application WO2020 / 063824 A1 discloses a preparation method of ((5-nitroquinolin-8-yl)oxy)methyl isobutyryl-L-proline ester, and the preparation method is as follows:

[0005]

[0006] However, in the above preparation method, the conversion rate of the first step reaction is low, which in turn leads to a low yield of this step and ultimately a low yield of the overall synthetic route. Summary of the invention

[0007] In order to solve the technical problem that the conversion rate of the first step reaction in the above preparation method is low, the present invention provides a preparation method of aromatic ether compounds.

[0008] Therefore, the object of the present invention is to provide a method for preparing a compound as shown in formula VII, which comprises the following steps:

[0009] c) in a solvent, in the presence of a catalyst and a base, compound V reacts with compound 6 to obtain compound VII;

[0010]

[0011] wherein ring A is an aromatic ring or a heteroaromatic ring, preferably a 6- to 10-membered aromatic ring or a 5- to 10-membered heteroaromatic ring, more preferably a benzene ring, a naphthalene ring, a pyridine ring or a quinoline ring; and the hydroxyl group is connected to the carbon on ring A;

[0012] Each R1 is independently selected from Wherein, each R2 is independently selected from C1-C 20 Alkyl, preferably C1-C6 alkyl, more preferably methyl, ethyl, n-propyl or isopropyl; X is selected from halogen, preferably fluorine, chlorine, bromine or iodine;

[0013] k is 0 to the maximum number of substitutions that can be made on ring A; preferably k is an integer from 0 to 6; more preferably k is an integer from 0 to 4; further preferably k is 0, 1 or 2, and most preferably k is 1;

[0014] The solvent is a binary or higher solvent system selected from water, tetrahydrofuran, 2-methyltetrahydrofuran, ethyl acetate and dioxane.

[0015] In a preferred embodiment of the present invention, according to the method for preparing the compound of formula VII of the present invention, wherein in step c), the compound V is m and n are each independently 0, 1, 2 or 3; preferably m and n are each independently 0, 1, 2 or 3; more preferably Further more preferably

[0016] In another preferred embodiment of the present invention, according to the method for preparing the compound of formula VII of the present invention, wherein in step c), the compound V is The compound VII is m and n are each independently 0, 1, 2 or 3;

[0017] Preferably, the compound V is The compound VII is m and n are each independently 0, 1, 2 or 3;

[0018] More preferably, the compound V is The compound VII is

[0019] Further more preferably, the compound V is The compound VII is

[0020] In another preferred embodiment of the present invention, according to the method for preparing the compound of formula VII of the present invention, wherein in step c), the halogen is fluorine, chlorine, bromine or iodine.

[0021] In another preferred embodiment of the present invention, according to the method for preparing the compound as shown in Formula VII of the present invention, wherein in step c), the solvent is selected from a binary solvent system or a ternary solvent system of water, tetrahydrofuran, 2-methyltetrahydrofuran, ethyl acetate and dioxane.

[0022] In another preferred embodiment of the present invention, according to the method for preparing the compound as shown in Formula VII of the present invention, wherein, in step c), the solvent is any one of the binary solvent systems of water / tetrahydrofuran, water / 2-methyltetrahydrofuran and water / ethyl acetate; or, any one of the ternary solvent systems of water / 2-methyltetrahydrofuran / tetrahydrofuran and water / 2-methyltetrahydrofuran / dioxane; the solvent is preferably a binary solvent system of water / tetrahydrofuran or a ternary solvent system of water / 2-methyltetrahydrofuran / tetrahydrofuran; more preferably a ternary solvent system of water / 2-methyltetrahydrofuran / tetrahydrofuran. In the binary solvent system, the volume ratio of water to organic solvent is preferably 10:15 to 15:0.1, more preferably 0.8:1 to 1.2:1, and further more preferably 1:1. In the ternary solvent system, the volume ratio of the three is preferably 10:15:15 to 15:5:5, more preferably 3:2:1 to 2.25:0.5:1, and further more preferably 2:1:1; wherein the "volume ratio of the three" refers to the volume ratio of the three substances appearing in the aforementioned ternary system in sequence.

[0023] In another preferred embodiment of the present invention, according to the method for preparing the compound as shown in Formula VII of the present invention, wherein in step c), the catalyst is a conventional quaternary ammonium phase transfer catalyst, preferably one or more of tetrabutylammonium hydroxide, tetrabutylammonium acetate, tetrabutylammonium hydrogen sulfate and tetrabutylammonium chloride, more preferably tetrabutylammonium hydroxide.

[0024] In another preferred embodiment of the present invention, according to the method for preparing the compound of formula VII of the present invention, wherein in step c), the base is one or both of sodium bicarbonate and potassium bicarbonate, preferably sodium bicarbonate.

[0025] In another preferred embodiment of the present invention, according to the method for preparing the compound of formula VII of the present invention, wherein in step c), the molar ratio of the compound V to the catalyst is 1:0.01 to 1:0.3, preferably 1:0.05 to 1:0.2, more preferably 1:0.1.

[0026] In another preferred embodiment of the present invention, according to the method for preparing the compound of formula VII of the present invention, wherein in step c), the molar ratio of the compound V to the base is 1:2.5 to 1:15, for example 1:3, preferably 1:6 to 1:10, more preferably 1:6 to 1:8, and further more preferably 1:7 to 1:8.

[0027] In another preferred embodiment of the present invention, according to the method for preparing the compound of formula VII of the present invention, wherein in step c), the molar ratio of compound V to compound 6 is 1:1 to 1:5, preferably 1:2 to 1:3, more preferably 1:2.5 to 1:2.7.

[0028] In another preferred embodiment of the present invention, according to the method for preparing the compound of formula VII according to the present invention, wherein in step c), the volume / mass ratio of the solvent to the compound V is 20 mL / g to 50 mL / g, preferably 24 mL / g to 45 mL / g, more preferably 25 mL / g to 40 mL / g, further more preferably 25 mL / g to 35 mL / g, and most preferably 30 mL / g.

[0029] In another preferred embodiment of the present invention, according to the method for preparing the compound of formula VII of the present invention, wherein in step c), the reaction temperature of the reaction is 20°C to 35°C, preferably 25°C to 30°C.

[0030] In another preferred embodiment of the present invention, the method for preparing the compound of formula VII according to the present invention may further include the following steps before step c):

[0031] b) Compound 3 is hydrolyzed in a solvent in the presence of a base to obtain compound 4,

[0032]

[0033] In step b), the solvent is preferably a mixed solvent of 2-methyltetrahydrofuran and water; and the base is preferably lithium hydroxide.

[0034] Before step b), the method may further include the following steps:

[0035] a) In a solvent, in the presence of a base, compound 1 reacts with compound 2 to obtain compound 3,

[0036]

[0037] In step a), the solvent is preferably dichloromethane; the base is preferably one or both of triethylamine and diisopropylethylamine, more preferably triethylamine.

[0038] The present invention further provides a method for preparing a compound as shown in formula VIII, characterized in that it comprises the following steps:

[0039] d) in a solvent, in the presence of a base, compound 4 reacts with compound VII to obtain compound VIII,

[0040]

[0041] Wherein, ring A is an aromatic ring or a heteroaromatic ring, preferably a 6- to 10-membered aromatic ring or a 5- to 10-membered heteroaromatic ring, more preferably a benzene ring, a naphthalene ring, a pyridine ring, or a quinoline ring; -OCH2Cl is connected to the carbon on ring A;

[0042] Each R1 is independently selected from Wherein, each R2 is independently selected from C1-C 20 Alkyl, preferably C1-C6 alkyl, more preferably methyl, ethyl, n-propyl or isopropyl; X is selected from halogen, preferably fluorine, chlorine, bromine or iodine;

[0043] k is 0 to the maximum number of substitutions that can be made on ring A; preferably k is an integer from 0 to 6; more preferably k is an integer from 0 to 4; further preferably k is 0, 1 or 2, and most preferably k is 1;

[0044] The compound VII is prepared according to the preparation method of the compound represented by formula VII described in the present invention.

[0045] In a preferred embodiment of the present invention, according to the method for preparing the compound of formula VIII of the present invention, wherein, in step d), the solvent is one or more of DMF, NMP and ACN, preferably DMF.

[0046] In another preferred embodiment of the present invention, according to the method for preparing the compound of formula VIII of the present invention, wherein, in step d), the base is one or more of potassium carbonate, cesium carbonate and sodium carbonate, preferably potassium carbonate.

[0047] In another preferred embodiment of the present invention, according to the method for preparing the compound of formula VIII of the present invention, wherein, in step d), the molar ratio of the compound 4 to the base is 1-1.5:1, preferably 1.2:1.

[0048] In another preferred embodiment of the present invention, according to the method for preparing the compound of formula VIII of the present invention, wherein, in step d), the molar ratio of the compound 4 to the compound VII is preferably 1-1.5:1, more preferably 1.2:1.

[0049] In another preferred embodiment of the present invention, according to the method for preparing the compound of formula VIII of the present invention, wherein, in step d), the ratio of the volume of the solvent to the mass of the compound 4 is 8:1 mL / g to 12:1 mL / g, preferably 10:1 mL / g.

[0050] In another preferred embodiment of the present invention, according to the method for preparing the compound of formula VIII of the present invention, wherein in step d), the reaction temperature of the reaction is 20°C to 30°C.

[0051] According to the method for preparing the compound as shown in Formula VIII of the present invention, after step d), a step e of separating and purifying compound 8 may be further included. The step e) preferably includes the following steps: dissolving the compound VIII obtained in step d) in a positive solvent, and then mixing it with an anti-solvent to obtain a crystal of compound VIII. The step e) more preferably includes the following steps: mixing the mixed solution obtained after the reaction in step d) with water, separating the liquids to obtain an organic phase; extracting the organic phase with ethyl acetate and removing water, and concentrating under reduced pressure to obtain a crude product; dissolving the crude product in a positive solvent, and then mixing it with an anti-solvent to obtain a crystal of compound VIII.

[0052] The dehydration may be performed using saturated saline water; preferably, after the dehydration using saturated saline water, the water is dried over anhydrous sodium sulfate and filtered before the reduced pressure concentration is performed.

[0053] Wherein, the positive solvent is preferably ethyl acetate.

[0054] Wherein, the anti-solvent is preferably petroleum ether.

[0055] In another preferred embodiment of the present invention, according to the method for preparing the compound of formula VIII of the present invention, wherein the compound VII is The compound VIII is

[0056] Without violating the common sense in the art, the above-mentioned preferred conditions can be arbitrarily combined to obtain the preferred embodiments of the present invention.

[0057] The reagents and raw materials used in the present invention are commercially available.

[0058] The positive and progressive effect of the present invention is that the preparation method of the aromatic ether compound of the present invention can greatly improve the conversion rate of the first step reaction, thereby improving the yield of the step and the total yield of the entire reaction route (the reaction route for preparing compound VIII). The preparation method of the aromatic ether compound of the present invention greatly simplifies the post-treatment and purification operations for preparing compound VII. It only needs to simply filter the reaction liquid, wash the filter cake, and dry it to obtain a highly pure compound VII, and the compound VII in the filtrate can also be extracted by simple concentration and crystallization, thereby avoiding purification methods such as column chromatography that are difficult to implement in industry, and is therefore suitable for industrial scale-up production. DETAILED DESCRIPTION

[0059] The present invention will be described in more detail below in conjunction with embodiments. The embodiments of the present invention are only used to illustrate the technical solutions of the present invention, and are not intended to limit the essence and scope of the present invention.

[0060] Hereinafter, TEA is triethylamine; DCM is dichloromethane; 2-Me-THF is 2-methyltetrahydrofuran; TBAOH is tetra-n-butylammonium hydroxide; THF is tetrahydrofuran; and DMF is N,N-dimethylformamide.

[0061] Hereinafter, LCMS refers to Agilent 1260 infinity II liquid phase + G6125B single quadrupole mass spectrometer.

[0062] In the following, the purity analysis method of the samples is as follows: Kinetex EVO C18 (50×4.6 mm, 5 μm, ) column, acetonitrile-water was used as the mobile phase for gradient elution, the flow rate was 1.5 mL / min, and the detection wavelengths were 210 nm and 254 nm.

[0063] Hereinafter, the model of hydrogen spectrum is WNMR-I-400MHz.

[0064] Hereinafter, silica gel column chromatography uses Yantai Huanghai Silica Gel 200-300 mesh silica gel as a carrier.

[0065] The synthetic route of embodiment is as follows:

[0066]

[0067] Table 1 Experimental parameters and experimental results of the embodiments and comparative examples

[0068]

[0069]

[0070] Example 1: Preparation of 5-nitro-8-chloromethoxyquinoline (7)

[0071] Compound 5 (1 g, 5.28 mmol, 1 eq) was placed in a 1 L round-bottom flask, sodium bicarbonate (2.64 g, 31.7 mmol, 6 eq) was added, followed by 20 mL of water, and stirred at room temperature. Then, an aqueous solution of tetrabutylammonium hydroxide (0.34 g, 0.528 mmol, 0.1 eq, 40 w.t. % in water) and 20 mL of THF were added, and stirred at room temperature for 30 minutes. Compound 6 (1.74 g, 10.56 mmol, 2.0 eq) was slowly added dropwise to the reaction flask, and the temperature was maintained at 25-30 ° C during the addition process. After about 15 minutes of dropwise addition, the reaction was continued at 25-30 ° C for 1.5 hours, and a large amount of compound 7 was precipitated. Afterwards, the mixed system obtained by the reaction was analyzed by LCMS, and the results showed that the conversion rate of compound 5 was 82.7%.

[0072] MS calculated value: 238.1; MS found value: 239.1 [M+H] + .

[0073] Example 2: Preparation of 5-nitro-8-chloromethoxyquinoline (7)

[0074] Compound 5 (1 g, 5.28 mmol, 1 eq) was placed in a 1 L round bottom flask, sodium bicarbonate (2.64 g, 31.7 mmol, 6 eq) was added, followed by 20 mL of water, stirred at room temperature, and then an aqueous solution of tetrabutylammonium hydroxide (0.34 g, 0.528 mmol, 0.1 eq, 40 w.t. % in water) and 20 mL of 2-Me-THF were added, and stirred at room temperature for 30 minutes. Compound 6 (1.74 g, 10.56 mmol, 2.0 eq) was slowly added dropwise to the reaction flask, and the temperature was maintained at 25-30° C. during the addition process. After about 15 minutes of addition, the reaction was continued at 25-30° C. for 1.5 hours, and a large amount of compound 7 was precipitated. Afterwards, the reaction mixture was analyzed by LCMS, and the results showed that the conversion rate of compound 5 was 75.2%.

[0075] MS calculated value: 238.1; MS found value: 239.1 [M+H] + .

[0076] Example 3: Preparation of 5-nitro-8-chloromethoxyquinoline (7)

[0077] Compound 5 (1 g, 5.28 mmol, 1 eq) was placed in a 1 L round bottom flask, sodium bicarbonate (2.64 g, 31.7 mmol, 6 eq) was added, followed by 20 mL of water, stirred at room temperature, and then an aqueous solution of tetrabutylammonium hydroxide (0.34 g, 0.528 mmol, 0.1 eq, 40 w.t. % in water) and 20 mL of ethyl acetate were added, and stirred at room temperature for 30 minutes. Compound 6 (1.74 g, 10.56 mmol, 2.0 eq) was slowly added dropwise to the reaction flask, and the temperature was maintained at 25-30° C. during the addition process. After about 15 minutes of dropwise addition, the reaction was continued at 25-30° C. for 1.5 hours, and a large amount of compound 7 was precipitated. Afterwards, the reaction mixture was analyzed by LCMS, and the results showed that the conversion rate of compound 5 was 73.8%.

[0078] MS calculated value: 238.1; MS found value: 239.1 [M+H] + .

[0079] Example 4: Preparation of 5-nitro-8-chloromethoxyquinoline (7)

[0080] Compound 5 (5 g, 26.3 mmol, 1 eq) was placed in a 1 L round bottom flask, sodium bicarbonate (15.5 g, 197.3 mmol, 7.5 eq) was added, followed by 100 mL of water, stirred at room temperature, and then an aqueous solution of tetrabutylammonium hydroxide (1.7 g, 2.63 mmol, 0.1 eq, 40 w.t. % in water) and 80 mL of THF were added, and stirred at room temperature for 30 minutes. Compound 6 (10.9 g, 65.8 mmol, 2.5 eq) was dissolved in 20 mL of THF and slowly added dropwise to the reaction flask, the temperature was maintained at 25-30 ° C during the addition process, and the reaction was continued at 25-30 ° C for 1.5 hours after about 15 minutes of addition, and a large amount of compound 7 was precipitated. Afterwards, the reaction mixture was analyzed by LCMS, and the results showed that the conversion rate of compound 5 was 98.1%.

[0081] MS calculated value: 238.1; MS found value: 239.1 [M+H] + .

[0082] Example 5: Preparation of 5-nitro-8-chloromethoxyquinoline (7)

[0083] Compound 5 (5 g, 26.3 mmol, 1 eq) was placed in a 1 L round bottom flask, potassium bicarbonate (19.8 g, 197.3 mmol, 7.5 eq) was added, followed by 100 mL of water, stirred at room temperature, and then an aqueous solution of tetrabutylammonium hydroxide (1.7 g, 2.63 mmol, 0.1 eq, 40 w.t. % in water) and 80 mL of 2-Me-THF were added, and stirred at room temperature for 30 minutes. Compound 6 (10.9 g, 65.8 mmol, 2.5 eq) was dissolved in 20 mL of 2-Me-THF and slowly added dropwise to the reaction flask, the temperature was maintained at 25-30° C. during the addition process, and the reaction was continued at 25-30° C. for 1.5 hours after about 15 minutes of addition, and a large amount of compound 7 was precipitated. Afterwards, the reaction mixture was analyzed by LCMS, and the results showed that the conversion rate of compound 5 was 80%.

[0084] MS calculated value: 238.1; MS found value: 239.1 [M+H] + .

[0085] Example 6: Preparation of 5-nitro-8-chloromethoxyquinoline (7)

[0086] Compound 5 (10 g, 52.6 mmol, 1 eq) was placed in a 3 L round bottom flask, sodium bicarbonate (35.7 g, 426.2 mmol, 8.1 eq) was added, followed by 200 mL of water, stirred at room temperature, and then an aqueous solution of tetrabutylammonium hydroxide (3.4 g, 5.26 mmol, 0.1 eq, 40 w.t. % in water) and 150 mL of THF were added, and stirred at room temperature for 30 minutes. Compound 6 (23.4 g, 142.1 mmol, 2.7 eq) was dissolved in 50 mL of THF and slowly added dropwise to the reaction flask, the temperature was maintained at 25-30 ° C during the addition process, and the reaction was continued at 25-30 ° C for 1.5 hours after about 15 minutes of addition, and a large amount of compound 7 was precipitated. Afterwards, the reaction mixture was analyzed by LCMS, and the results showed that the conversion rate of compound 5 was 77.9%.

[0087] MS calculated value: 238.1; MS found value: 239.1 [M+H] + .

[0088] Example 7: Preparation of 5-nitro-8-chloromethoxyquinoline (7)

[0089] Compound 5 (10 g, 52.6 mmol, 1 eq) was placed in a 3 L round bottom flask, sodium bicarbonate (33.1 g, 394.6 mmol, 7.5 eq) was added, followed by 200 mL of water, stirred at room temperature, and then an aqueous solution of tetrabutylammonium hydroxide (3.4 g, 5.26 mmol, 0.1 eq, 40 w.t. % in water) and 150 mL of THF were added, and stirred at room temperature for 30 minutes. Compound 6 (21.7 g, 131.6 mmol, 2.5 eq) was dissolved in 50 mL of THF and slowly added dropwise to the reaction flask, the temperature was maintained at 25-30 ° C during the addition process, and the reaction was continued at 25-30 ° C for 1.5 hours after about 15 minutes of addition, and a large amount of compound 7 was precipitated. Afterwards, the reaction mixture was analyzed by LCMS, and the results showed that the conversion rate of compound 5 was 95.8%.

[0090] MS calculated value: 238.1; MS found value: 239.1 [M+H] + .

[0091] Example 8: Preparation of 5-nitro-8-chloromethoxyquinoline (7)

[0092] Compound 5 (10 g, 52.6 mmol, 1 eq) was placed in a 3 L round bottom flask, sodium bicarbonate (33.1 g, 394.6 mmol, 7.5 eq) was added, followed by 200 mL of water, stirred at room temperature, and then an aqueous solution of tetrabutylammonium hydroxide (3.4 g, 5.26 mmol, 0.1 eq, 40 w.t. % in water) and 100 mL of 2-Me-THF and 50 mL of THF were added, and stirred at room temperature for 30 minutes. Compound 6 (21.7 g, 131.6 mmol, 2.5 eq) was dissolved in 50 mL of THF and slowly added dropwise to the reaction flask, the temperature was maintained at 25-30 ° C during the addition process, and the reaction was continued at 25-30 ° C for 1.5 hours after about 15 minutes of addition, and a large amount of compound 7 was precipitated. Afterwards, the reaction mixture was analyzed by LCMS, and the results showed that the conversion rate of compound 5 was 98.7%.

[0093] MS calculated value: 238.1; MS found value: 239.1 [M+H] + .

[0094] Example 9: Preparation of 5-nitro-8-chloromethoxyquinoline (7)

[0095] Compound 5 (10 g, 52.6 mmol, 1 eq) was placed in a 3 L round bottom flask, sodium bicarbonate (33.1 g, 394.6 mmol, 7.5 eq) was added, followed by 150 mL of water, stirred at room temperature, and then an aqueous solution of tetrabutylammonium hydroxide (3.4 g, 5.26 mmol, 0.1 eq, 40 w.t. % in water), 75 mL of 2-Me-THF and 50 mL of THF were added, and stirred at room temperature for 30 minutes. Compound 6 (21.7 g, 131.6 mmol, 2.5 eq) was dissolved in 25 mL of THF and slowly added dropwise to the reaction flask, the temperature was maintained at 25-30 ° C during the addition process, and the reaction was continued at 25-30 ° C for 1.5 hours after about 15 minutes of addition, and a large amount of compound 7 was precipitated. Afterwards, the reaction mixture was analyzed by LCMS, and the results showed that the conversion rate of compound 5 was 97.1%.

[0096] MS calculated value: 238.1; MS found value: 239.1 [M+H] + .

[0097] Example 10: Preparation of 5-nitro-8-chloromethoxyquinoline (7)

[0098] Compound 5 (10 g, 52.6 mmol, 1 eq) was placed in a 3 L round bottom flask, sodium bicarbonate (33.1 g, 394.6 mmol, 7.5 eq) was added, followed by 100 mL of water, stirred at room temperature, and then an aqueous solution of tetrabutylammonium hydroxide (3.4 g, 5.26 mmol, 0.1 eq, 40 w.t. % in water), 50 mL of 2-Me-THF and 35 mL of THF were added, and stirred at room temperature for 30 minutes. Compound 6 (21.7 g, 131.6 mmol, 2.5 eq) was dissolved in 15 mL of THF and slowly added dropwise to the reaction flask, the temperature was maintained at 25-30 ° C during the addition process, and the reaction was continued at 25-30 ° C for 1.5 hours after about 15 minutes of addition, and a large amount of compound 7 was precipitated. Afterwards, the reaction mixture was analyzed by LCMS, and the result showed that the conversion rate of compound 5 was 85.8%.

[0099] MS calculated value: 238.1; MS found value: 239.1 [M+H] + .

[0100] Example 11: Preparation of 5-nitro-8-chloromethoxyquinoline (7)

[0101] Compound 5 (30 g, 157.8 mmol, 1 eq) was placed in a 3 L round bottom flask, sodium bicarbonate (99.4 g, 1183.2 mmol, 7.5 eq) was added, followed by 450 mL of water, stirred at room temperature, and then an aqueous solution of tetrabutylammonium hydroxide (10.24 g, 15.8 mmol, 0.1 eq, 40 w.t. % in water), 100 mL of 2-Me-THF and 150 mL of THF were added, and stirred at room temperature for 30 minutes. Compound 6 (65.1 g, 394.4 mmol, 2.5 eq) was dissolved in 50 mL of THF and slowly added dropwise to the reaction flask, the temperature was maintained at 25-30 ° C during the addition process, and after about 15 minutes of dropwise addition, the mixture was reacted at 25-30 ° C for 1.5 hours, and a large amount of compound 7 was precipitated. Afterwards, the reaction mixture was analyzed by LCMS, and the result showed that the conversion rate of compound 5 was 89.2%.

[0102] MS calculated value: 238.1; MS found value: 239.1 [M+H] + .

[0103] Example 12: Preparation of ((5-nitroquinolin-8-yl)oxy)methylisobutyryl-L-proline ester (8)

[0104] 1. Preparation of 5-nitro-8-chloromethoxyquinoline (7)

[0105] Compound 5 (30 g, 157.8 mmol, 1 eq) was placed in a 3 L round bottom flask, sodium bicarbonate (99.4 g, 1183.2 mmol, 7.5 eq) was added, followed by 450 mL of water, stirred at room temperature, and then an aqueous solution of tetrabutylammonium hydroxide (10.24 g, 15.8 mmol, 0.1 eq, 40 w.t. % in water), 300 mL of 2-Me-THF and 100 mL of THF were added, and stirred at room temperature for 30 minutes. Compound 6 (65.1 g, 394.4 mmol, 2.5 eq) was dissolved in 50 mL of THF and slowly added dropwise to the reaction flask, the temperature was maintained at 25-30° C. during the addition process, and the reaction was continued at 25-30° C. for 1.5 hours after about 15 minutes of addition, and a large amount of compound 7 was precipitated. Afterwards, the mixed system obtained by the reaction was analyzed by LCMS, and the result showed that the conversion rate of compound 5 was 88.0%. Afterwards, the mixture was filtered, the filter cake was rinsed with 50 mL of water, and the filter cake was dried to obtain 22 g of the product as a yellow solid with a yield of 59% and a purity of 92%.

[0106] 1H-NMR (400 MHz, CDCl3) δ: 9.18 (d, J=8.8Hz, 1H), 9.06 (m, 1H), 8.51 (dd, J=8.8Hz, 1.2Hz, 1H), 7.76 (m, 1H), 7.45 (d, J=1.2Hz, 1H), 6.25 (s, 2H).

[0107] MS calculated value: 238.1; MS found value: 239.1 [M+H] + .

[0108] 2. Preparation of L-isobutyrylproline methyl ester (3)

[0109] L-Proline methyl ester hydrochloride (1) (30 g, 181.1 mmol) was placed in a 1L three-necked flask, 300 mL of dichloromethane was added, and the mixture was cooled in an ice bath. Under nitrogen protection, triethylamine (37.6 g, 371.3 mmol) was slowly added dropwise while stirring and stirred for 20 minutes. Then isobutyryl chloride (2) (20.3 g, 190.2 mmol) was slowly added dropwise at 0-10°C and stirred for 1 hour. Then the temperature was raised to 20°C for reaction for 2 hours and the reaction was stopped. After that, 30 mL of water was added and the mixture was allowed to stand for separation to obtain an organic phase. The organic phase was concentrated under reduced pressure, and the crude product obtained by concentration was dissolved in 150 mL of ethyl acetate, and then washed with 30 mL of water and 30 mL of saturated brine in sequence. The obtained organic phase was dried over anhydrous sodium sulfate, filtered, and the filtrate was concentrated under reduced pressure to obtain 34.8 g of L-isobutyrylproline methyl ester (3) as a colorless oil with a yield of 96.4% and a purity of 96.5%.

[0110] MS calculated value: 199.2; MS found value: 200.2 [M+H] + .

[0111] 3. Preparation of L-isobutyrylproline (4)

[0112] L-isobutyrylproline methyl ester (3) (34.8 g, 124.5 mmol) was dissolved in 210 mL 2-Me-THF and 140 mL water was added, and then LiOH·H2O (10.4 g, 249.0 mmol) was added. The reaction solution was stirred at 20°C for 2 hours. After the reaction was stopped, the solution was allowed to stand and separated to obtain an aqueous phase. The pH of the aqueous phase was adjusted to 4-5 with HCl aqueous solution (35 mL, 6N), and then extracted with dichloromethane (70 mL x 2). The obtained organic phase was dried over anhydrous sodium sulfate, filtered, and the filtrate was concentrated under reduced pressure to obtain 29.5 g of L-isobutyrylproline (4) as a white solid with a yield of 91.3% and a purity of 99%.

[0113] 1H-NMR(400 MHz, DMSO-d6): δ12.47 (s, 1H), 4.20-4.24 (m, 1H), 3.58-3.55 (m, 2H), 2.68-2.65 (m, 1H), 2.19-2 .14 ​​(m, 1H), 1.92-1.85 (m, 2H), 1.83-1.78 (m, 1H), 0.95 (d, J=3.6Hz, 3H), 0.89 (d, J=3.6Hz.3H).

[0114] MS calculated value: 185.2; MS found value: 186.2 [M+H] + .

[0115] 4. Preparation of ((5-nitroquinolin-8-yl)oxy)methylisobutyryl-L-proline ester (8)

[0116] Dissolve L-isobutyrylproline (4) (40 g, 215.6 mmol, 1.2 eq) in 400 mL of anhydrous DMF, and add potassium carbonate (25 g, 179.6 mmol, 1.0 eq) while stirring at room temperature. After stirring at room temperature for 25 minutes, add 5-nitro-8-chloromethoxyquinoline (7) (42.8 g, 179.6 mmol, 1.0 eq) and react at room temperature for 1.5 hours. After the reaction stops, add 2 L of water to dilute, and then separate the liquid to obtain an organic phase. The organic phase is then extracted with ethyl acetate (1 L x 2), then washed with 1 L of saturated brine, dried over anhydrous sodium sulfate, filtered, and the filtrate is concentrated under reduced pressure to obtain 65 g of a crude product. The crude product is dissolved in 130 mL of ethyl acetate at room temperature, and 390 mL of petroleum ether is added for recrystallization. The crystals were filtered to obtain 62 g of ((5-nitroquinolin-8-yl)oxy)methylisobutyryl-L-proline ester (8) with a purity of 99.1% and a yield of 89.2%.

[0117] 1 H-NMR (400MHz, DMSO-d6) δ: 9.05 (d, J=4.0Hz, 1H), 9.00 (d, J=8.8Hz, 1H), 8.56 (d, J= 8.8Hz, 1H), 7.89-7.86 (dd, J=4.0Hz, 8.8Hz, 1H), 7.55 (d, J=8.8Hz, 1H), 6.24-6.11( m, 2H), 4.36-4.33 (m, 1H), 3.58-3.55 (m, 2H), 2.68-2.65 (m, 1H), 2.19-2.14 (m, 1H), 1.92-1.85 (m, 2H), 1.83-1.78 (m, 1H), 0.95 (d, J=6.8Hz.3H), 0.89 (d, J=6.8Hz.3H).

[0118] MS calculated value: 387.3; MS found value: 388.3 [M+H] + .

[0119] Example 13: Preparation of 5-nitro-8-chloromethoxyquinoline (7)

[0120] Compound 5 (10 g, 52.6 mmol, 1 eq) was placed in a 3 L round bottom flask, sodium bicarbonate (33.1 g, 394.6 mmol, 7.5 eq) was added, followed by 150 mL of water, stirred at room temperature, and then an aqueous solution of tetrabutylammonium hydroxide (3.4 g, 5.26 mmol, 0.1 eq, 40 w.t. % in water), 75 mL of 2-Me-THF and 50 mL of THF were added, and stirred at room temperature for 30 minutes. Compound 6 (21.7 g, 131.6 mmol, 2.5 eq) was dissolved in 25 mL of THF and slowly added dropwise to the reaction flask, the temperature was maintained at 25-30 ° C during the addition process, and the reaction was continued at 25-30 ° C for 1.5 hours after about 15 minutes of addition, and a large amount of compound 7 was precipitated. Afterwards, the mixed system obtained by the reaction was analyzed by LCMS, and the result showed that the conversion rate of compound 5 was 93.5%. Afterwards, the mixture was filtered, the filter cake was rinsed with 50 mL of water, and the filter cake was dried to obtain 7 g of product as a yellow solid with a yield of 56% and a purity of 98.1%.

[0121] 1H-NMR (400MHz, CDCl3) δ: 9.18 (d, J=8.8Hz, 1H), 9.06 (m, 1H), 8.51 (dd, J=8.8Hz, 1.2Hz, 1H), 7.76 (m, 1H), 7.45 (d, J=1.2Hz, 1H), 6.25 (s, 2H).

[0122] MS calculated value: 238.1; MS found value: 239.1 [M+H] + .

[0123] Example 14: Preparation of 5-nitro-8-chloromethoxyquinoline (7)

[0124] Compound 5 (30 g, 157.8 mmol, 1 eq) was placed in a 3 L round bottom flask, sodium bicarbonate (79.5 g, 947 mmol, 6 eq) was added, followed by 360 mL of water, stirred at room temperature, and then an aqueous solution of tetrabutylammonium hydroxide (10.24 g, 15.8 mmol, 0.1 eq, 40 w.t. % in water), 180 mL of 2-Me-THF and 140 mL of THF were added, and stirred at room temperature for 30 minutes. Compound 6 (52.1 g, 315.5 mmol, 2 eq) was dissolved in 40 mL of THF and slowly added dropwise to the reaction flask, the temperature was maintained at 25-30° C. during the addition process, and the reaction was continued at 25-30° C. for about 15 minutes, and then reacted for 1.5 hours at 25-30° C. A large amount of compound 7 was precipitated, and then the mixed system obtained by the reaction was analyzed by LCMS, and the result showed that the conversion rate of compound 5 was 90.4%. Afterwards, the mixture was filtered, the filter cake was rinsed with 50 mL of water, and the filter cake was dried to obtain 25 g of the product as a yellow solid with a yield of 66.4% and a purity of 96.5%.

[0125] 1 H-NMR (400MHz, CDCl3) δ: 9.18 (d, J=8.8Hz, 1H), 9.06 (m, 1H), 8.51 (dd, J=8.8Hz, 1.2Hz, 1H), 7.76 (m, 1H), 7.45 (d, J=1.2Hz, 1H), 6.25 (s, 2H).

[0126] MS calculated value: 238.1; MS found value: 239.1 [M+H] + .

[0127] Comparative Example 1: Preparation of ((5-nitroquinolin-8-yl)oxy)methylisobutyryl-L-proline ester (8)

[0128]

[0129] Step 1: Preparation of 5-nitro-8-chloromethoxyquinoline (7)

[0130] At room temperature, sodium bicarbonate aqueous solution (150 mL, 0.88 mol / L) and tetrabutylammonium hydrogen sulfate (1.78 g, 5.24 mmol) were added to a dichloromethane (150 mL) solution of nitroquinoline (5) (10.00 g, 52.59 mmol) and stirred for 20 minutes. Chloromethyl chlorosulfonate (17.44 g, 105.7 mmol) was added dropwise to the reaction system and stirred at room temperature for 16 hours. Afterwards, the mixed system obtained by the reaction was analyzed by LCMS, and the results showed that the conversion rate of compound 5 was 30.7%. Afterwards, the reaction solution was filtered and then separated to obtain an organic phase. The organic phase was washed with a saturated potassium carbonate solution (20 mL) and a saturated saline solution (20 mL) in sequence, dried over anhydrous sodium sulfate, filtered, and the filtrate was concentrated under reduced pressure. The obtained solid was purified by silica gel column chromatography (eluent: dichloromethane: methanol = 20:1, the ratio is volume ratio) to obtain 2.5 g of 5-nitro-8-chloromethoxyquinoline (7) with a yield of 20% and a purity of 98%.

[0131] 1 H-NMR (400MHz, CDCl3) δ: 9.18 (d, J=8.8Hz, 1H), 9.06 (m, 1H), 8.51 (dd, J=8.8Hz, 1.2Hz, 1H), 7.76 (m, 1H), 7.45 (d, J=1.2Hz, 1H), 6.25 (s, 2H).

[0132] MS calculated value: 238.1; MS found value: 239.1 [M+H] + .

[0133] Step 2: Preparation of 1-(tert-butyl)2-(((5-nitroquinolin-8-yl)oxy)methyl)(S)-pyrrole-1,2-carbonic acid diester (9)

[0134] At room temperature, 5-nitro-8-chloromethoxyquinoline (7) (1.5 g, 6.3 mmol) and L-Boc proline (2.02 g, 9.4 mmol) were dissolved in 15 mL of DMF, potassium carbonate (1.73 g, 12.6 mmol) was added, and the mixture was reacted at room temperature for 3 hours. 70 mL of water was added to the reaction solution, and the mixture was separated to obtain an organic phase. The organic phase was extracted with ethyl acetate (50 mL x 2), then washed with saturated brine, dried over anhydrous sodium sulfate, filtered, and the filtrate was concentrated under reduced pressure. The residue was purified by silica gel column chromatography (eluent: PE: EA = 1: 1, the ratio is volume ratio) to obtain 2.8 g of 1-(tert-butyl) 2-(((5-nitroquinolin-8-yl)oxy)methyl) (S)-pyrrole-1,2-carbonic acid diester (9) as a yellow oil, with a yield of 106% and a purity of 97%.

[0135] MS calculated value: 417.1; MS found value: 418.2 [M+H] + .

[0136] Step 3: Preparation of ((5-nitroquinolin-8-yl)oxy)methyl-L-proline ester hydrochloride (10)

[0137] 1-(tert-Butyl) 2-(((5-nitroquinolin-8-yl)oxy)methyl) (S)-pyrrole-1,2-carbonic acid diester (9) (2.8 g, 6.71 mmol) was placed in 30 mL of HCl in dioxane (4 M) at 0°C and stirred at room temperature for 20 minutes. The reaction solution was concentrated under reduced pressure to obtain 2.3 g of ((5-nitroquinolin-8-yl)oxy)methyl L-proline ester hydrochloride (10) as a white solid with a yield of 97% and a purity of 96%.

[0138] MS calculated value: 317.1; MS found value: 318.1 [M+H] + .

[0139] Step 4: Preparation of ((5-nitroquinolin-8-yl)oxy)methylisobutyryl-L-proline ester (8)

[0140] At room temperature, ((5-nitroquinolin-8-yl)oxy)methyl-L-proline ester hydrochloride (10) (150 mg, 0.43 mmol) was placed in 10 mL of DCM, cooled to 0-5°C in an ice bath, isobutyryl chloride (0.86 mmol) was added, and then TEA (170 mg, 1.72 mmol) was slowly added. After the addition, the mixture was stirred at room temperature for 20 minutes, and the reaction solution was concentrated under reduced pressure. The residue was purified by silica gel column chromatography (eluent: PE: EA = 1: 1, the ratio is volume ratio) to obtain ((5-nitroquinolin-8-yl)oxy)methyl isobutyryl-L-proline ester (8) 41 mg, yield 24.6%, purity 99%.

[0141] 1H-NMR (400MHz, DMSO-d6) δ: 9.05 (d, J=4.0Hz, 1H), 9.01 (d, J=8.8Hz, 1H), 8.58 (d, J= 8.8Hz, 1H), 7.80-7.86 (dd, J=4.0Hz, 8.8Hz, 1H), 7.55 (d, J=8.8Hz, 1H), 6.22-6.14( m, 2H), 4.36-4.33 (m, 1H), 3.55-3.55 (m, 2H), 2.68-2.65 (m, 1H), 2.19-2.13 (m, 1H), 1.92-1.85 (m, 2H), 1.86-1.78 (m, 1H), 0.94 (d, J=6.8Hz.3H), 0.89 (d, J=6.8Hz.3H).

[0142] MS calculated value: 387.3; MS found value: 388.3 [M+H] + .

[0143] According to the relevant experimental data in Table 1, the preparation method of the aromatic ether compound of the present invention can greatly improve the conversion rate of the reaction of preparing compound 7 from compound 5 and compound 6, thereby improving the yield of this step and the total yield of the entire reaction route (reaction route for preparing compound 8).

[0144] In addition, at the end of the reaction of compound 5 and compound 6 to prepare compound 7, a large amount of compound 7 will be precipitated in the reaction system, so the preparation method of the aromatic ether compound of the present invention greatly simplifies the post-treatment and purification operation of preparing compound 7. It only needs to simply filter the reaction solution, wash the filter cake, and dry it to obtain compound 7 with a purity of more than 92%. Some embodiments can even obtain compound 7 with a purity of more than 98%, and compound 7 in the filtrate can also be extracted by simple concentration and crystallization, thereby avoiding purification methods that are difficult to implement in industry such as column chromatography. Therefore, the above-mentioned preparation method of the present invention is suitable for industrial scale-up production. Here, the inventor of the present invention also hopes to explain that the chloromethyl ether fragment contained in compound 7 is sensitive to acid, alkali and heat, so the preparation and purification are difficult, and there are few public literature reports, and the inventor of the present invention has studied the preparation method of compound 7 with great advantages of the present invention after a lot of research.

Claims

1. A method for preparing a compound as shown in formula VII, It is characterized in that It includes the following steps: c) in a solvent, in the presence of a catalyst and a base, compound V reacts with compound 6 to obtain compound VII; wherein ring A is an aromatic ring or a heteroaromatic ring; the hydroxyl group is connected to the carbon on ring A; Each R 1 Each independently selected from -R 2 , -NO 2 、-NO、 -SR 2 、-OR 2 and -X; where each R 2 Each independently is C 1 -C 20 Alkyl; X is halogen; k is 0 to the maximum number of substitutions that can be made on ring A; The solvent is any one of the binary solvent systems of water / tetrahydrofuran, water / 2-methyltetrahydrofuran and water / ethyl acetate; or any one of the ternary solvent systems of water / 2-methyltetrahydrofuran / tetrahydrofuran and water / 2-methyltetrahydrofuran / dioxane.

2. The method for preparing the compound of formula VII according to claim 1, It is characterized in that Ring A is a 6- to 10-membered aromatic ring or a 5- to 10-membered heteroaromatic ring.

3. The method for preparing the compound of formula VII according to claim 1, It is characterized in that Ring A is a benzene ring, a naphthalene ring, a pyridine ring or a quinoline ring.

4. The method for preparing the compound of formula VII according to claim 1, It is characterized in that Each R 2 Each independently is C 1 -C 6 alkyl.

5. The method for preparing the compound of formula VII according to claim 1, It is characterized in that Each R 2 Each is independently methyl, ethyl, n-propyl or isopropyl.

6. The method for preparing the compound of formula VII according to claim 1, It is characterized in that X is fluorine, chlorine, bromine or iodine.

7. The method for preparing the compound of formula VII according to claim 1, It is characterized in that k is an integer from 0 to 6.

8. The method for preparing the compound of formula VII according to claim 1, It is characterized in that k is an integer from 0 to 4.

9. The method for preparing the compound of formula VII according to claim 1, It is characterized in that k is 0, 1 or 2.

10. The method for preparing the compound of formula VII according to claim 1, It is characterized in that k is 1.

11. A method for preparing a compound according to formula VII according to claim 1, It is characterized in that In step c), the compound V is in, Each R 1 Each independently selected from -R 2 , -NO 2 、-NO、 -SR 2 、-OR 2 and -X; where each R 2 Each independently is C 1 -C 20 Alkyl; X is halogen; m and n are each independently 0, 1, 2 or 3.

12. The method for preparing the compound of formula VII according to claim 1, It is characterized in that In step c), the compound V is m and n are each independently 0, 1, 2 or 3.

13. A method for preparing a compound according to formula VII according to claim 1, It is characterized in that In step c), the compound V is 14. A method for preparing a compound of formula VII according to claim 1, It is characterized in that In step c), the compound V is 15. A method for preparing a compound of formula VII according to claim 1, It is characterized in that In step c), the solvent is a water / tetrahydrofuran binary solvent system or a water / 2-methyltetrahydrofuran / tetrahydrofuran ternary solvent system.

16. A method for preparing a compound of formula VII according to claim 1, It is characterized in that In step c), the solvent is a ternary solvent system of water / 2-methyltetrahydrofuran / tetrahydrofuran.

17. A method for preparing a compound of formula VII according to claim 1, It is characterized in that In step c), in the binary solvent system, the volume ratio of water to the organic solvent is 10:15 to 15:0.

1.

18. A method for preparing a compound of formula VII according to claim 1, It is characterized in that In step c), in the binary solvent system, the volume ratio of water to the organic solvent is 0.8:1 to 1.2:

1.

19. The method for preparing the compound of formula VII according to claim 1, It is characterized in that In step c), in the binary solvent system, the volume ratio of water to the organic solvent is 1:

1.

20. The method for preparing the compound of formula VII according to claim 1, It is characterized in that In step c), in the ternary solvent system, the volume ratio of water / 2-methyltetrahydrofuran / tetrahydrofuran or water / 2-methyltetrahydrofuran / dioxane is 10:15:15 to 15:5:

5.

21. A method for preparing a compound of formula VII according to claim 1, It is characterized in that In step c), in the ternary solvent system, water / 2-methyltetrahydrofuran / tetrahydrofuran or water / 2-methyltetrahydrofuran / dioxane is 3:2:1 to 2.25:0.5:

1.

22. A method for preparing a compound of formula VII according to claim 1, It is characterized in that In step c), in the ternary solvent system, the volume ratio of water / 2-methyltetrahydrofuran / tetrahydrofuran or water / 2-methyltetrahydrofuran / dioxane is 2:1:

1.

23. A method for preparing a compound of formula VII according to claim 1, It is characterized in that In step c), the catalyst is a quaternary ammonium phase transfer catalyst.

24. A method for preparing a compound of formula VII according to claim 1, It is characterized in that In step c), the catalyst is one or more of tetrabutylammonium hydroxide, tetrabutylammonium acetate, tetrabutylammonium hydrogen sulfate and tetrabutylammonium chloride.

25. A method for preparing a compound of formula VII according to claim 1, It is characterized in that In step c), the catalyst is tetrabutylammonium hydroxide.

26. A method for preparing a compound of formula VII according to claim 1, It is characterized in that In step c), the base is selected from one or both of sodium bicarbonate and potassium bicarbonate.

27. A method for preparing a compound of formula VII according to claim 1, It is characterized in that In step c), the base is sodium bicarbonate.

28. A method for preparing a compound of formula VII according to claim 1, It is characterized in that In step c), the molar ratio of the compound V to the catalyst is 1:0.01 to 1:0.

3.

29. A method for preparing a compound of formula VII according to claim 1, It is characterized in that In step c), the molar ratio of the compound V to the catalyst is 1:0.05 to 1:0.

2.

30. A method for preparing a compound of formula VII according to claim 1, It is characterized in that In step c), the molar ratio of the compound V to the catalyst is 1:0.

1.

31. A method for preparing a compound according to formula VII according to claim 1, It is characterized in that In step c), the molar ratio of the compound V to the base is 1:2.5 to 1:

15.

32. A method for preparing a compound according to formula VII according to claim 1, It is characterized in that In step c), the molar ratio of the compound V to the base is 1:6 to 1:

10.

33. A method for preparing a compound of formula VII according to claim 1, It is characterized in that In step c), the molar ratio of the compound V to the base is 1:6 to 1:

8.

34. A method for preparing a compound of formula VII according to claim 1, It is characterized in that In step c), the molar ratio of the compound V to the base is 1:7 to 1:

8.

35. A method for preparing a compound of formula VII according to claim 1, It is characterized in that In step c), the molar ratio of the compound V to the compound 6 is 1:1 to 1:

5.

36. A method for preparing a compound of formula VII according to claim 1, It is characterized in that In step c), the molar ratio of the compound V to the compound 6 is 1:2 to 1:

3.

37. A method for preparing a compound of formula VII according to claim 1, It is characterized in that In step c), the molar ratio of the compound V to the compound 6 is 1:2.5 to 1:2.

7.

38. A method for preparing a compound of formula VII according to claim 1, It is characterized in that In step c), the volume / mass ratio of the solvent to the compound V is 20 mL / g to 50 mL / g.

39. A method for preparing a compound of formula VII according to claim 1, It is characterized in that In step c), the volume / mass ratio of the solvent to the compound V is 24 mL / g to 45 mL / g.

40. A method for preparing a compound of formula VII according to claim 1, It is characterized in that In step c), the volume / mass ratio of the solvent to the compound V is 25 mL / g to 40 mL / g.

41. A method for preparing a compound of formula VII according to claim 1, It is characterized in that In step c), the volume / mass ratio of the solvent to the compound V is 25 mL / g to 35 mL / g.

42. A method for preparing a compound of formula VII according to claim 1, It is characterized in that In step c), the volume / mass ratio of the solvent to the compound V is 30 mL / g.

43. A method for preparing a compound according to formula VII according to claim 1, It is characterized in that In step c), the reaction temperature is 20°C to 35°C.

44. A method for preparing a compound according to formula VII according to claim 1, It is characterized in that In step c), the reaction temperature is 25°C to 30°C.

45. A method for preparing a compound as shown in formula VIII, It is characterized in that It includes the following steps: c) in a solvent, in the presence of a catalyst and a base, compound V reacts with compound 6 to obtain compound VII; wherein ring A is an aromatic ring or a heteroaromatic ring; the hydroxyl group is connected to the carbon on ring A; The solvent is any one of the binary solvent systems of water / tetrahydrofuran, water / 2-methyltetrahydrofuran and water / ethyl acetate; or any one of the ternary solvent systems of water / 2-methyltetrahydrofuran / tetrahydrofuran and water / 2-methyltetrahydrofuran / dioxane; d) in a solvent, in the presence of a base, compound 4 reacts with compound VII to obtain compound VIII, Wherein, ring A is an aromatic ring or a heteroaromatic ring; -OCH 2 Cl is attached to the carbon on ring A; Each R 1 Each independently selected from -R 2 , -NO 2 、-NO、 -SR 2 、-OR 2 , and -X; where each R 2 Each independently is C 1 -C 20 Alkyl; X is halogen; k is from 0 to the maximum number of substitutions that can be made on ring A.

46. ​​A method for preparing a compound of formula VIII according to claim 45, It is characterized in that In step d), the solvent is one or more of DMF, NMP and ACN.

47. A method for preparing a compound of formula VIII according to claim 45, It is characterized in that In step d), the solvent is DMF.

48. A method for preparing a compound of formula VIII according to claim 45, It is characterized in that In step d), the base is one or more of potassium carbonate, cesium carbonate and sodium carbonate.

49. A method for preparing a compound of formula VIII according to claim 45, It is characterized in that In step d), the base is potassium carbonate.

50. A method for preparing a compound of formula VIII according to claim 45, It is characterized in that In step d), the molar ratio of the compound 4 to the base is 1-1.5:

1.

51. A method for preparing a compound of formula VIII according to claim 45, It is characterized in that In step d), the molar ratio of the compound 4 to the base is 1.2:

1.

52. A method for preparing a compound of formula VIII according to claim 45, It is characterized in that In step d), the molar ratio of the compound 4 to the compound VII is 1-1.5:

1.

53. A method for preparing a compound of formula VIII according to claim 45, It is characterized in that In step d), the molar ratio of the compound 4 to the compound VII is 1.2:

1.

54. A method for preparing a compound of formula VIII according to claim 45, It is characterized in that In step d), the ratio of the volume of the solvent to the mass of the compound 4 is 8:1 mL / g to 12:1 mL / g.

55. A method for preparing a compound of formula VIII according to claim 45, It is characterized in that In step d), the ratio of the volume of the solvent to the mass of the compound 4 is 10:1 mL / g.

56. A method for preparing a compound of formula VIII according to claim 45, It is characterized in that In step d), the reaction temperature is 20°C to 30°C.

57. A method for preparing a compound of formula VIII according to claim 45, It is characterized in that Ring A is a 6- to 10-membered aromatic ring or a 5- to 10-membered heteroaromatic ring.

58. A method for preparing a compound of formula VIII according to claim 45, It is characterized in that Ring A is a benzene ring, a naphthalene ring, a pyridine ring or a quinoline ring.

59. A method for preparing a compound of formula VIII according to claim 45, It is characterized in that Each R 2 Each independently is C 1 -C 6 alkyl.

60. A method for preparing a compound of formula VIII according to claim 45, It is characterized in that Each R 2 Each is independently methyl, ethyl, n-propyl or isopropyl.

61. A method for preparing a compound of formula VIII according to claim 45, It is characterized in that X is fluorine, chlorine, bromine or iodine.

62. A method for preparing a compound of formula VIII according to claim 45, It is characterized in that k is an integer from 0 to 6.

63. A method for preparing a compound of formula VIII according to claim 45, It is characterized in that k is an integer from 0 to 4.

64. A method for preparing a compound of formula VIII according to claim 45, It is characterized in that k is 0, 1 or 2.

65. A method for preparing a compound of formula VIII according to claim 45, It is characterized in that k is 1.

66. A method for preparing a compound of formula VIII according to claim 45, It is characterized in that In step c), the compound V is in, Each R 1 Each independently selected from -R 2 , -NO 2 、-NO、 -SR 2 、-OR 2 , 2 and -X; where each R 2 Each independently is C 1 -C 20 Alkyl; X is halogen; m and n are each independently 0, 1, 2 or 3.

67. A method for preparing a compound of formula VIII according to claim 45, It is characterized in that In step c), the compound V is m and n are each independently 0, 1, 2 or 3.

68. A method for preparing a compound of formula VIII according to claim 45, It is characterized in that In step c), the compound V is 69. A method for preparing a compound of formula VIII according to claim 45, It is characterized in that In step c), the compound V is 70. A method for preparing a compound of formula VIII according to claim 45, It is characterized in that In step c), the solvent is a binary solvent system of water / tetrahydrofuran or a ternary solvent system of water / 2-methyltetrahydrofuran / tetrahydrofuran.

71. A method for preparing a compound of formula VIII according to claim 45, It is characterized in that In step c), the solvent is a ternary solvent system of water / 2-methyltetrahydrofuran / tetrahydrofuran.

72. A method for preparing a compound of formula VIII according to claim 45, It is characterized in that In step c), in the binary solvent system, the volume ratio of water to the organic solvent is 10:15 to 15:0.

1.

73. A method for preparing a compound of formula VIII according to claim 45, It is characterized in that In step c), in the binary solvent system, the volume ratio of water to the organic solvent is 0.8:1 to 1.2:

1.

74. A method for preparing a compound of formula VIII according to claim 45, It is characterized in that In step c), in the binary solvent system, the volume ratio of water to the organic solvent is 1:

1.

75. A method for preparing a compound of formula VIII according to claim 45, It is characterized in that In step c), in the ternary solvent system, the volume ratio of water / 2-methyltetrahydrofuran / tetrahydrofuran or water / 2-methyltetrahydrofuran / dioxane is 10:15:15 to 15:5:

5.

76. A method for preparing a compound of formula VIII according to claim 45, It is characterized in that In step c), in the ternary solvent system, the volume ratio of water / 2-methyltetrahydrofuran / tetrahydrofuran or water / 2-methyltetrahydrofuran / dioxane is 2:1:

1.

77. A method for preparing a compound of formula VIII according to claim 45, It is characterized in that In step c), the catalyst is a quaternary ammonium phase transfer catalyst.

78. A method for preparing a compound of formula VIII according to claim 45, It is characterized in that In step c), the catalyst is one or more of tetrabutylammonium hydroxide, tetrabutylammonium acetate, tetrabutylammonium hydrogen sulfate and tetrabutylammonium chloride.

79. A method for preparing a compound of formula VIII according to claim 45, It is characterized in that In step c), the catalyst is tetrabutylammonium hydroxide.

80. A method for preparing a compound of formula VIII according to claim 45, It is characterized in that In step c), the base is selected from one or both of sodium bicarbonate and potassium bicarbonate.

81. A method for preparing a compound of formula VIII according to claim 45, It is characterized in that In step c), the base is sodium bicarbonate.

82. A method for preparing a compound of formula VIII according to claim 45, It is characterized in that In step c), the molar ratio of the compound V to the catalyst is 1:0.01 to 1:0.

3.

83. A method for preparing a compound of formula VIII according to claim 45, It is characterized in that In step c), the molar ratio of the compound V to the catalyst is 1:0.05 to 1:0.

2.

84. A method for preparing a compound of formula VIII according to claim 45, It is characterized in that In step c), the molar ratio of the compound V to the catalyst is 1:0.

1.

85. A method for preparing a compound of formula VIII according to claim 45, It is characterized in that In step c), the molar ratio of the compound V to the base is 1:2.5 to 1:

15.

86. A method for preparing a compound of formula VIII according to claim 45, It is characterized in that In step c), the molar ratio of the compound V to the base is 1:6 to 1:

10.

87. A method for preparing a compound of formula VIII according to claim 45, It is characterized in that In step c), the molar ratio of the compound V to the base is 1:6 to 1:

8.

88. A method for preparing a compound of formula VIII according to claim 45, It is characterized in that In step c), the molar ratio of the compound V to the base is 1:7 to 1:

8.

89. A method for preparing a compound of formula VIII according to claim 45, It is characterized in that In step c), the molar ratio of the compound V to the compound 6 is 1:1 to 1:

5.

90. A method for preparing a compound of formula VIII according to claim 45, It is characterized in that In step c), the molar ratio of the compound V to the compound 6 is 1:2 to 1:

3.

91. A method for preparing a compound of formula VIII according to claim 45, It is characterized in that In step c), the molar ratio of the compound V to the compound 6 is 1:2.5 to 1:2.

7.

92. A method for preparing a compound of formula VIII according to claim 45, It is characterized in that In step c), the volume / mass ratio of the solvent to the compound V is 20 mL / g to 50 mL / g.

93. A method for preparing a compound of formula VIII according to claim 45, It is characterized in that In step c), the volume / mass ratio of the solvent to the compound V is 24 mL / g to 45 mL / g.

94. A method for preparing a compound of formula VIII according to claim 45, It is characterized in that In step c), the volume / mass ratio of the solvent to the compound V is 25 mL / g to 40 mL / g.

95. A method for preparing a compound of formula VIII according to claim 45, It is characterized in that In step c), the volume / mass ratio of the solvent to the compound V is 25 mL / g to 35 mL / g.

96. A method for preparing a compound of formula VIII according to claim 45, It is characterized in that In step c), the volume / mass ratio of the solvent to the compound V is 30 mL / g.

97. A method for preparing a compound of formula VIII according to claim 45, It is characterized in that In step c), the reaction temperature is 20°C to 35°C.

98. A method for preparing a compound of formula VIII according to claim 45, It is characterized in that In step c), the reaction temperature is 25°C to 30°C.

99. A method for preparing a compound of formula VIII according to claim 45, It is characterized in that After step d), the method further comprises step e) of isolating and purifying compound VIII.

100. A method for preparing a compound of formula VIII according to claim 99, It is characterized in that The step e) comprises the following steps: dissolving the compound VIII obtained in the step d) in a positive solvent, and then mixing with an anti-solvent to obtain a crystal of the compound VIII.

101. A method for preparing a compound of formula VIII according to claim 100, It is characterized in that The positive solvent is ethyl acetate; the anti-solvent is petroleum ether.

102. A method for preparing a compound of formula VIII according to claim 45, It is characterized in that The step c) further comprises the following steps: b) Compound 3 is hydrolyzed in a solvent in the presence of a base to obtain compound 4, 103. A method for preparing a compound of formula VIII according to claim 102, It is characterized in that In step b), the solvent is a mixed solvent of 2-methyltetrahydrofuran and water.

104. A method for preparing a compound of formula VIII according to claim 102, It is characterized in that In step b), the base is lithium hydroxide.

105. A method for preparing a compound of formula VIII according to claim 102, It is characterized in that The step b) further comprises the following steps: a) In a solvent, in the presence of a base, compound 1 reacts with compound 2 to obtain compound 3, 106. A method for preparing a compound of formula VIII according to claim 105, It is characterized in that In step a), the solvent is dichloromethane.

107. A method for preparing a compound of formula VIII according to claim 105, It is characterized in that In step a), the base is one or both of triethylamine and diisopropylethylamine.

108. A method for preparing a compound of formula VIII according to claim 105, It is characterized in that In step a), the base is triethylamine.